Home Healthcare Healthcare IT Artificial Intelligence for Drug Discovery and Development Market

Artificial Intelligence for Drug Discovery and Development Market Size, Share & Trends Analysis Report By Application (Drug optimisation and repurposing, Preclinical testing, Others), By Therapeutic Area (Oncology, Neurodegenerative Diseases, Infectious Disease, Others), By End Use (Pharmaceutical & Biotechnology, CRO, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: December 16, 2025 | Author: Debashree B | Format: | Report Code: SR2538DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Artificial Intelligence for Drug Discovery and Development Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Drug optimisation and repurposing
    2. Preclinical testing
    3. Others
  2. Artificial Intelligence for Drug Discovery and Development Market, By Therapeutic Area 2022-2034 (USD MILLION/ Units)
    1. Oncology
    2. Neurodegenerative Diseases
    3. Infectious Disease
    4. Others
  3. Artificial Intelligence for Drug Discovery and Development Market, By End Use 2022-2034 (USD MILLION/ Units)
    1. Pharmaceutical & Biotechnology
    2. CRO
    3. Others
  4. Regional Artificial Intelligence for Drug Discovery and Development Market
    1. North America
      1. North America Artificial Intelligence for Drug Discovery and Development Market By Application 2022-2034 (USD MILLION/ Units)
        1. Drug optimisation and repurposing
        2. Preclinical testing
        3. Others
      2. North America Artificial Intelligence for Drug Discovery and Development Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurodegenerative Diseases
        3. Infectious Disease
        4. Others
      3. North America Artificial Intelligence for Drug Discovery and Development Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology
        2. CRO
        3. Others
      4. U.S.
        1. Drug optimisation and repurposing
        2. Preclinical testing
        3. Others
        4. Oncology
        5. Neurodegenerative Diseases
        6. Infectious Disease
        7. Others
        8. Pharmaceutical & Biotechnology
        9. CRO
        10. Others
      5. Canada
        1. Drug optimisation and repurposing
        2. Preclinical testing
        3. Others
        4. Oncology
        5. Neurodegenerative Diseases
        6. Infectious Disease
        7. Others
        8. Pharmaceutical & Biotechnology
        9. CRO
        10. Others
    2. Europe
      1. Europe Artificial Intelligence for Drug Discovery and Development Market By Application 2022-2034 (USD MILLION/ Units)
        1. Drug optimisation and repurposing
        2. Preclinical testing
        3. Others
      2. Europe Artificial Intelligence for Drug Discovery and Development Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurodegenerative Diseases
        3. Infectious Disease
        4. Others
      3. Europe Artificial Intelligence for Drug Discovery and Development Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology
        2. CRO
        3. Others
      4. U.K.
        1. Drug optimisation and repurposing
        2. Preclinical testing
        3. Others
        4. Oncology
        5. Neurodegenerative Diseases
        6. Infectious Disease
        7. Others
        8. Pharmaceutical & Biotechnology
        9. CRO
        10. Others
      5. Germany
        1. Drug optimisation and repurposing
        2. Preclinical testing
        3. Others
        4. Oncology
        5. Neurodegenerative Diseases
        6. Infectious Disease
        7. Others
        8. Pharmaceutical & Biotechnology
        9. CRO
        10. Others
      6. France
        1. Drug optimisation and repurposing
        2. Preclinical testing
        3. Others
        4. Oncology
        5. Neurodegenerative Diseases
        6. Infectious Disease
        7. Others
        8. Pharmaceutical & Biotechnology
        9. CRO
        10. Others
      7. Spain
        1. Drug optimisation and repurposing
        2. Preclinical testing
        3. Others
        4. Oncology
        5. Neurodegenerative Diseases
        6. Infectious Disease
        7. Others
        8. Pharmaceutical & Biotechnology
        9. CRO
        10. Others
      8. Italy
        1. Drug optimisation and repurposing
        2. Preclinical testing
        3. Others
        4. Oncology
        5. Neurodegenerative Diseases
        6. Infectious Disease
        7. Others
        8. Pharmaceutical & Biotechnology
        9. CRO
        10. Others
      9. Russia
        1. Drug optimisation and repurposing
        2. Preclinical testing
        3. Others
        4. Oncology
        5. Neurodegenerative Diseases
        6. Infectious Disease
        7. Others
        8. Pharmaceutical & Biotechnology
        9. CRO
        10. Others
      10. Nordic
        1. Drug optimisation and repurposing
        2. Preclinical testing
        3. Others
        4. Oncology
        5. Neurodegenerative Diseases
        6. Infectious Disease
        7. Others
        8. Pharmaceutical & Biotechnology
        9. CRO
        10. Others
      11. Benelux
        1. Drug optimisation and repurposing
        2. Preclinical testing
        3. Others
        4. Oncology
        5. Neurodegenerative Diseases
        6. Infectious Disease
        7. Others
        8. Pharmaceutical & Biotechnology
        9. CRO
        10. Others
      12. Rest of Europe
        1. Drug optimisation and repurposing
        2. Preclinical testing
        3. Others
        4. Oncology
        5. Neurodegenerative Diseases
        6. Infectious Disease
        7. Others
        8. Pharmaceutical & Biotechnology
        9. CRO
        10. Others
    3. APAC
      1. APAC Artificial Intelligence for Drug Discovery and Development Market By Application 2022-2034 (USD MILLION/ Units)
        1. Drug optimisation and repurposing
        2. Preclinical testing
        3. Others
      2. APAC Artificial Intelligence for Drug Discovery and Development Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurodegenerative Diseases
        3. Infectious Disease
        4. Others
      3. APAC Artificial Intelligence for Drug Discovery and Development Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology
        2. CRO
        3. Others
      4. China
        1. Drug optimisation and repurposing
        2. Preclinical testing
        3. Others
        4. Oncology
        5. Neurodegenerative Diseases
        6. Infectious Disease
        7. Others
        8. Pharmaceutical & Biotechnology
        9. CRO
        10. Others
      5. Korea
        1. Drug optimisation and repurposing
        2. Preclinical testing
        3. Others
        4. Oncology
        5. Neurodegenerative Diseases
        6. Infectious Disease
        7. Others
        8. Pharmaceutical & Biotechnology
        9. CRO
        10. Others
      6. Japan
        1. Drug optimisation and repurposing
        2. Preclinical testing
        3. Others
        4. Oncology
        5. Neurodegenerative Diseases
        6. Infectious Disease
        7. Others
        8. Pharmaceutical & Biotechnology
        9. CRO
        10. Others
      7. India
        1. Drug optimisation and repurposing
        2. Preclinical testing
        3. Others
        4. Oncology
        5. Neurodegenerative Diseases
        6. Infectious Disease
        7. Others
        8. Pharmaceutical & Biotechnology
        9. CRO
        10. Others
      8. Australia
        1. Drug optimisation and repurposing
        2. Preclinical testing
        3. Others
        4. Oncology
        5. Neurodegenerative Diseases
        6. Infectious Disease
        7. Others
        8. Pharmaceutical & Biotechnology
        9. CRO
        10. Others
      9. Taiwan
        1. Drug optimisation and repurposing
        2. Preclinical testing
        3. Others
        4. Oncology
        5. Neurodegenerative Diseases
        6. Infectious Disease
        7. Others
        8. Pharmaceutical & Biotechnology
        9. CRO
        10. Others
      10. South East Asia
        1. Drug optimisation and repurposing
        2. Preclinical testing
        3. Others
        4. Oncology
        5. Neurodegenerative Diseases
        6. Infectious Disease
        7. Others
        8. Pharmaceutical & Biotechnology
        9. CRO
        10. Others
      11. Rest of Asia-Pacific
        1. Drug optimisation and repurposing
        2. Preclinical testing
        3. Others
        4. Oncology
        5. Neurodegenerative Diseases
        6. Infectious Disease
        7. Others
        8. Pharmaceutical & Biotechnology
        9. CRO
        10. Others
    4. Middle East and Africa
      1. Middle East and Africa Artificial Intelligence for Drug Discovery and Development Market By Application 2022-2034 (USD MILLION/ Units)
        1. Drug optimisation and repurposing
        2. Preclinical testing
        3. Others
      2. Middle East and Africa Artificial Intelligence for Drug Discovery and Development Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurodegenerative Diseases
        3. Infectious Disease
        4. Others
      3. Middle East and Africa Artificial Intelligence for Drug Discovery and Development Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology
        2. CRO
        3. Others
      4. UAE
        1. Drug optimisation and repurposing
        2. Preclinical testing
        3. Others
        4. Oncology
        5. Neurodegenerative Diseases
        6. Infectious Disease
        7. Others
        8. Pharmaceutical & Biotechnology
        9. CRO
        10. Others
      5. Turkey
        1. Drug optimisation and repurposing
        2. Preclinical testing
        3. Others
        4. Oncology
        5. Neurodegenerative Diseases
        6. Infectious Disease
        7. Others
        8. Pharmaceutical & Biotechnology
        9. CRO
        10. Others
      6. Saudi Arabia
        1. Drug optimisation and repurposing
        2. Preclinical testing
        3. Others
        4. Oncology
        5. Neurodegenerative Diseases
        6. Infectious Disease
        7. Others
        8. Pharmaceutical & Biotechnology
        9. CRO
        10. Others
      7. South Africa
        1. Drug optimisation and repurposing
        2. Preclinical testing
        3. Others
        4. Oncology
        5. Neurodegenerative Diseases
        6. Infectious Disease
        7. Others
        8. Pharmaceutical & Biotechnology
        9. CRO
        10. Others
      8. Egypt
        1. Drug optimisation and repurposing
        2. Preclinical testing
        3. Others
        4. Oncology
        5. Neurodegenerative Diseases
        6. Infectious Disease
        7. Others
        8. Pharmaceutical & Biotechnology
        9. CRO
        10. Others
      9. Nigeria
        1. Drug optimisation and repurposing
        2. Preclinical testing
        3. Others
        4. Oncology
        5. Neurodegenerative Diseases
        6. Infectious Disease
        7. Others
        8. Pharmaceutical & Biotechnology
        9. CRO
        10. Others
      10. Rest of MEA
        1. Drug optimisation and repurposing
        2. Preclinical testing
        3. Others
        4. Oncology
        5. Neurodegenerative Diseases
        6. Infectious Disease
        7. Others
        8. Pharmaceutical & Biotechnology
        9. CRO
        10. Others
    5. LATAM
      1. LATAM Artificial Intelligence for Drug Discovery and Development Market By Application 2022-2034 (USD MILLION/ Units)
        1. Drug optimisation and repurposing
        2. Preclinical testing
        3. Others
      2. LATAM Artificial Intelligence for Drug Discovery and Development Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Neurodegenerative Diseases
        3. Infectious Disease
        4. Others
      3. LATAM Artificial Intelligence for Drug Discovery and Development Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology
        2. CRO
        3. Others
      4. Brazil
        1. Drug optimisation and repurposing
        2. Preclinical testing
        3. Others
        4. Oncology
        5. Neurodegenerative Diseases
        6. Infectious Disease
        7. Others
        8. Pharmaceutical & Biotechnology
        9. CRO
        10. Others
      5. Mexico
        1. Drug optimisation and repurposing
        2. Preclinical testing
        3. Others
        4. Oncology
        5. Neurodegenerative Diseases
        6. Infectious Disease
        7. Others
        8. Pharmaceutical & Biotechnology
        9. CRO
        10. Others
      6. Argentina
        1. Drug optimisation and repurposing
        2. Preclinical testing
        3. Others
        4. Oncology
        5. Neurodegenerative Diseases
        6. Infectious Disease
        7. Others
        8. Pharmaceutical & Biotechnology
        9. CRO
        10. Others
      7. Chile
        1. Drug optimisation and repurposing
        2. Preclinical testing
        3. Others
        4. Oncology
        5. Neurodegenerative Diseases
        6. Infectious Disease
        7. Others
        8. Pharmaceutical & Biotechnology
        9. CRO
        10. Others
      8. Colombia
        1. Drug optimisation and repurposing
        2. Preclinical testing
        3. Others
        4. Oncology
        5. Neurodegenerative Diseases
        6. Infectious Disease
        7. Others
        8. Pharmaceutical & Biotechnology
        9. CRO
        10. Others
      9. Rest of LATAM
        1. Drug optimisation and repurposing
        2. Preclinical testing
        3. Others
        4. Oncology
        5. Neurodegenerative Diseases
        6. Infectious Disease
        7. Others
        8. Pharmaceutical & Biotechnology
        9. CRO
        10. Others
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.